Pharmaceutical

Sermonix and Regor to enhance breast cancer treatment options

Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed at developing therapeutics in the breast oncology area.

Mar 25, 2025 - 06:00
Sermonix and Regor to enhance breast cancer treatment options
Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed at developing therapeutics in the breast oncology area.
Read the original article

Tags:

Previous Article

Ferroptosis Plays a Key Role in Immunosuppression

Next Article

Tempero secures $70m to advance addiction treatment candidate

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

JAMA’s new editor settles in, bringing open access and other changes

JAMA’s new editor settles in, bringing open access and ...

Mar 19, 2023

Weill Cancer Hub East launches to transform treatment

Weill Cancer Hub East launches to transform treatment

Mar 29, 2025

South Korea seeks to accelerate drug reimbursement administration process

South Korea seeks to accelerate drug reimbursement admi...

Jun 22, 2024